Baseline serum syndecan-4 predicts prognosis after the onset of acute exacerbation of idiopathic interstitial pneumonia.
Yuki SatoYoshinori TaninoXintao WangTakefumi NikaidoSuguru SatoKenichi MisaRyuichi TogawaCharles W FrevertMitsuru MunakataPublished in: PloS one (2017)
Baseline serum syndecan-4 is a possible prognostic biomarker after the onset of acute exacerbation of idiopathic interstitial pneumonia.